News
A study led by Bellvitge points out that fosfomycin can improve the treatment of bacteremia caused by S. aureus
Combining fosfomycin with other antibiotics can help eliminate the infection more quickly, however, is also associated with an increase in side effects.
The Clinical Research Unit in Clinical Trials revalidates its quality certification
The ISO 9001:2015 certification, granted by the Applus+ organization and globally recognized, confirms the excellence of the UICEC’s quality processes.
A Bellvitge study analyzes the clinical impact of amoxicillin resistance on invasive pneumococcal pneumonia
According to the results, amoxicillin may be associated with a less favourable clinical outcome, especially in cases with resistant strains and in people with a worse initial prognosis.
A study by the UB and IDIBELL identifies a key neurophysiological mechanism in the formation of memories in humans
A team from the Faculty of Psychology of the University of Barcelona (UB), the Institute of Neurosciences of the UB (UBNeuro) and the Bellvitge Biomedical Research Institute (IDIBELL) has identified for the first time in humans, and in a realistic environment, a key neurophysiological mechanism in memory formation: brain waves type Ripple, high-frequency electrical oscillations, […]
Quality and excellence guaranteed: the Biobank successfully passes the ISO 9001 audit
The HUB-ICO-IDIBELL Biobank has renewed its ISO 9001 certification.
SCALPEL: analyzing gene expression in high resolution
Researchers from IDIBELL and the UB present a new tool to study the post-transcriptional regulation of gene expression at single-cell resolution
Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis
The study confirms the improvement in severe lung affectation after COVID-19 thanks to the combination of pirfenidone and corticosteroids.
IDIBELL and Bellvitge Hospital receive funding to improve tolerance in kidney transplants
IDIBELL and the Bellvitge Hospital will promote a new project to improve immune tolerance in kidney transplant patients and reduce the risk of rejection.
Cognitive impairment in lung cancer, an undervalued disorder with new approaches and treatment perspectives
31% of patients already had symptoms of cognitive impairment at the time of lung cancer diagnosis, underscoring the importance of monitoring this disorder to improve patients’ quality of life.